Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinicopathologic analysis of low-stage sporadic ovarian carcinomas: a reappraisal.

The American journal of surgical pathology - 1 Mar 2013

Karamurzin Yevgeniy, Leitao Mario M, Soslow Robert A

Abstract excerpt

Current histologic criteria endorsed by World Health Organization for surface epithelial ovarian tumors suffer from less than optimal reproducibility and correlation with clinical outcomes. A modified approach for histologic subclassification of ovarian carcinomas (OCs), proposed by the group of Gilks and colleagues, has been shown to be reproducible and clinically meaningful. We hypothesized that this approach...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Disease-Free Survival
Share to Immunohistochemistry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kaplan-Meier Estimate

Share to Neoplasm Staging

Share to Ovarian Neoplasms

Share to Tissue Array Analysis

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 23282975
DOI: 10.1097/PAS.0b013e318272ff19

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinicopathologic analysis of low-stage sporadic ovarian carcinomas: a reappraisal.PMID 23282975Read ↗

BRCA1 Immunohistochemistry in a Molecularly Characterized Cohort of Ovarian High-Grade Serous CarcinomasSemantic proximity Read ↗

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalitiesSemantic proximity Read ↗

Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.Semantic proximity Read ↗

Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinomaSemantic proximity Read ↗

Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.Semantic proximity Read ↗

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.Semantic proximity Read ↗

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses.Semantic proximity Read ↗

Biology of epithelial ovarian cancer: implications for screening women at high genetic risk.Semantic proximity Read ↗

Pathology of ovarian cancers in BRCA1 and BRCA2 carriers.Semantic proximity Read ↗

Optimized p53 immunohistochemistry is an accurate predictor of <i>TP53</i> mutation in ovarian carcinomaSemantic proximity Read ↗

Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens fromBRCA1 heterozygotesSemantic proximity Read ↗

Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.